脓毒症休克与ARDS患者肾脏支持时机与结局:AKIKI试验事后分析
该研究为AKIKI随机临床试验的事后分析,纳入619例重症急性肾损伤患者,其中348例(56%)有脓毒症休克、207例(33%)有ARDS。按基线脓毒症状态、ARDS状态及严重度评分分层,比较早期与延迟启动肾脏替代治疗对60天死亡率的影响,发现早期启动策略并未改善60天死亡率,延迟策略可使部分患者避免RRT。
要点
- 早期启动RRT未改善脓毒症休克或ARDS合并重症AKI患者的60天死亡率。
- 延迟策略使45%脓毒症休克和46%ARDS患者免于RRT,且肾功能恢复更早。
- ARDS患者拔管成功时间不受RRT启动策略影响(P=0.43)。
核心结论
- 在重症急性肾损伤合并脓毒症休克或ARDS的患者中,早期启动肾脏替代治疗策略与60天死亡率改善无关。
研究设计与样本
- AKIKI随机临床试验的事后分析,共纳入619例患者,其中348例(56%)有脓毒症休克,207例(33%)有ARDS。
主要发现
- 基线脓毒症状态(P=0.28)、ARDS状态(P=0.94)、SAPS 3(P=0.77)和SOFA(P=0.46)对两种RRT启动策略的60天死亡率比较无显著影响。
- 延迟RRT启动策略使45%的脓毒症休克患者和46%的ARDS患者避免RRT。
- 延迟组尿量更高;脓毒症休克或ARDS患者中延迟策略的肾功能恢复更早(P<0.001和P=0.003)。
- ARDS患者拔管成功时间不受RRT策略影响(P=0.43)。
临床怎么用
- 对于脓毒症休克或ARDS合并重症急性肾损伤的患者,可考虑延迟启动RRT以避免不必要且有风险的操作。
局限性
- 本研究为AKIKI试验的事后分析,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: The optimal strategy for initiation of renal replacement therapy (RRT) in patients with severe acute kidney injury in the context of septic shock and acute respiratory distress syndrome (ARDS) is unknown. OBJECTIVES: To examine the effect of an early compared with a delayed RRT initiation strategy on 60-day mortality according to baseline sepsis status, ARDS status, and severity. METHODS: Post hoc analysis of the AKIKI (Artificial Kidney Initiation in Kidney Injury) trial. MEASUREMENTS AND MAIN RESULTS: Subgroups were defined according to baseline characteristics: sepsis status (Sepsis-3 definition), ARDS status (Berlin definition), Simplified Acute Physiology Score 3 (SAPS 3), and Sepsis-related Organ Failure Assessment (SOFA). Of 619 patients, 348 (56%) had septic shock and 207 (33%) had ARDS. We found no significant influence of the baseline sepsis status (P = 0.28), baseline ARDS status (P = 0.94), and baseline severity scores (P = 0.77 and P = 0.46 for SAPS 3 and SOFA, respectively) on the comparison of 60-day mortality according to RRT initiation strategy. A delayed RRT initiation strategy allowed 45% of patients with septic shock and 46% of patients with ARDS to escape RRT. Urine output was higher in the delayed group. Renal function recovery occurred earlier with the delayed RRT strategy in patients with septic shock or ARDS (P < 0.001 and P = 0.003, respectively). Time to successful extubation in patients with ARDS was not affected by RRT strategy (P = 0.43). CONCLUSIONS: Early RRT initiation strategy was not associated with any improvement of 60-day mortality in patients with severe acute kidney injury and septic shock or ARDS. Unnecessary and potentially risky procedures might often be avoided in these fragile populations. Clinical trial registered with www.clinicaltrials.gov (NCT 01932190).
引用
- Gaudry S, Hajage D, Schortgen F, et al. Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial. Am J Respir Crit Care Med. 2018. PMID: 29351007. doi:10.1164/rccm.201706-1255OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。